Boltz
Boltz is an AI-powered biotechnology company developing biomolecular models and software infrastructure to accelerate drug discovery and optimise the design of proteins, small molecules and biologics.
Boltz has raised €100M across 1 funding round from 9 investors, most recently a Series A round in Nov 2026. Based in London, UK; active in AI. Data as of Nov 2026.
London, UKboltz.com ↗
Total raised
€100M
€100,291,758
Funding rounds
1
Investors
9
distinct backers
Active since
2026-11
latest 2026-11
Funding by year
EUR raised per year · 2026 YTDBoltz — funding by year — interactive chart.
Data table
| Boltz — funding by year | |
|---|---|
| 2026 | €100M |
Signals
High confidenceRaise-next likelihood14
base rate 44% for Series A
- ▼ Raised very recently
- ▼ Low backer re-investment
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-11-19 | Series A | €100M | Amplify Partners,Andreessen Horowitz,Bessemer Venture Partners,F-Prime Capital,Greycroft Partners,Hummingbird and Benchling+3 more | View deal → |